Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?


BILICI A., USTAALIOĞLU B., ERCAN S., ORCUN A., Seker M., SALEPCI T., ...More

Cancer chemotherapy and pharmacology, vol.68, pp.309-16, 2011 (SCI-Expanded) identifier identifier identifier